📰 Ipid Management News
Page 28 - Ipid Management News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ipid Management. Real-time updates on events, politics, business and more.
August 12, 2022
Assessment of pericoronary fat volume and attenuation index showed potential for diagnosis and assessment of coronary heart disease, but not necessarily coronary lesions.
August 12, 2022
Atherosclerotic risk factors present in children as young as 29 days are associated with significant risk for arterial ischemic stroke in the fourth and fifth decades of life, a new study suggests.
August 11, 2022
Patients with rheumatoid arthritis are at greater risk for infection if theyre treated with tofacitinib than with a tumor necrosis factor inhibitor (TNFi), according to an industry-funded study.
August 11, 2022
South Asians, from India and elsewhere on the subcontinent, living in America have a higher risk of dying from atherosclerotic disease plus type 2 diabetes than other Americans.
August 9, 2022
An investigational drug targets the adipocyte to treat insulin resistance. The drug restores glucose absorption in animal models and could provide a new approach to type 2 diabetes.
August 8, 2022
A Mendelian randomization study appears to exonerate very low LDL-C but not therapies from altering cognition.
August 8, 2022
Patients prescribed medicines for asymptomatic conditions are far less likely to be adherent than those prescribed medicines for symptomatic conditions, according to a retrospective analysis.
July 21, 2022
Practice should more often heed FDA-recommended rosuvastatin dosages for patients with severe chronic kidney disease and step up monitoring for renal safety in such cases, experts say.
July 15, 2022
Similar benefits were seen with low, moderate, and high statin doses, as well as in cases of both mild and severe acute pancreatitis.
July 7, 2022
In a national study, investigators found that historical discriminatory housing practices were associated with higher modern-day cardiovascular disease and related risk factors.